Build A Bear Workshop Inc vs GeneDx Holdings Corp — how do they compare? Build A Bear Workshop Inc trades at $37.1 (market cap $461.88M), while GeneDx Holdings Corp trades at $81.96 (market cap $2.44B). The key difference: GeneDx Holdings Corp is far larger — about 5.3× Build A Bear Workshop Inc's market cap, and Build A Bear Workshop Inc pays a 2.5% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| BBW | WGS | |
|---|---|---|
Market Cap | $461.88M | $2.44B |
Sector | Consumer Cyclical | Technology |
52-Week High | $75.85 | $167.51 |
52-Week Low | $29.84 | $34.51 |
Enterprise Value | $561.32M | $2.48B |
Dividend Yield | 2.5% | — |
Signals from Pluang's Aura AI — not financial advice
Build-A-Bear Workshop (BBW) trades at $37.10, down 0.43% on the day, with a bullish technical signal from moving averages but neutral oscillators. The company shows strong profitability with a 10.48% net margin and 35.87% ROE, supported by recent earnings beats. A new CEO transition and Halloween product launches aim to drive engagement, while analyst consensus is strongly bullish with a $62.50 price target.
BBW presents a compelling value opportunity with a low P/E of 8.63 and consistent earnings outperformance, though near-term revenue headwinds and consumer caution pose risks. The stock's 72.7% buy rating and debt-free balance sheet underpin upside potential, but investors should monitor execution of growth initiatives amid economic pressures.
GeneDx Holdings Corp (WGS) trades at $82.07, up 5.38% in the past 24 hours, with technical indicators showing a bullish trend. The stock beat Q2 2026 EPS estimates but reported negative net income margins. Recent news highlights product expansion and institutional buying interest, though class-action lawsuits pose near-term sentiment risks.
Outlook is mixed: strong analyst buy ratings (90.9%) and a $79.25 consensus target suggest upside, but high valuation multiples and persistent losses require caution. Key risks include profitability challenges and legal overhangs, while revenue growth and market positioning offer long-term potential.
Trailing returns across standard periods
Build-A-Bear is a global retailer specializing in customizable stuffed animals. It offers an interactive make-your-own experience where customers choose, stuff, and dress their furry friends in-store or online.
Read more on BBW →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →